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Abstract
Background: Forces deployed to the first Gulf War report more ill health than veterans who did
not serve there. Many studies of post-Gulf morbidity are based on relatively small sample sizes and
selection bias is often a concern. In a setting where selection bias relating to the ill health of
veterans may be reduced, we: i) examined self-reported adult ill health in a large sample of male
UK Gulf War veterans and a demographically similar non-deployed comparison group; and ii)
explored self-reported ill health among veterans who believed that they had Gulf War syndrome.
Methods: This study uses data from a retrospective cohort study of reproduction and child health
in which a validated postal questionnaire was sent to all UK Gulf War veterans (GWV) and a
comparison cohort of Armed Service personnel who were not deployed to the Gulf (NGWV). The
cohort for analysis comprises 42,818 males who responded to the questionnaire.
Results: We confirmed that GWV report higher rates of general ill health. GWV were significantly
more likely to have reported at least one new medical symptom or disease since 1990 than NGWV
(61% versus 37%, OR 2.7, 95% CI 2.5–2.8). They were also more likely to report higher numbers
of symptoms. The strongest associations were for mood swings (OR 20.9, 95%CI 16.2–27.0),
memory loss/lack of concentration (OR 19.6, 95% CI 15.5–24.8), night sweats (OR 9.9, 95% CI 6.5–
15.2), general fatigue (OR 9.6, 95% CI 8.3–11.1) and sexual dysfunction (OR 4.6, 95%CI 3.2–6.6).
6% of GWV believed they had Gulf War syndrome (GWS), and this was associated with the highest
symptom reporting.
Conclusions: Increased levels of reported ill health among GWV were confirmed. This study was
the first to use a questionnaire which did not focus specifically on the veterans' symptoms
themselves. Nevertheless, the results are consistent with those of other studies of post-Gulf war
illness and thus strengthen overall findings in this area of research. Further examination of the
mechanisms underlying the reporting of ill health is required.
Background
Following the 1990–91 Gulf War there have been a
number of published reports highlighting the increased
morbidity of military personnel who served in the con-
flict. Studies from all over the world show that forces
deployed to the Gulf (GWV) report more ill health than
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veterans who did not serve there (NGWV) [1-7]. In terms
of the types of reported symptoms, different studies have
discovered a range of nonspecific chronic conditions.
Many research groups have noted that GWV are more
likely to suffer from substantial fatigue, symptoms of
post-traumatic stress, and psychological distress [1,2,4].
Others have also described peripheral, respiratory, gas-
trointestinal, psychological and concentration problems
[3].
Despite millions of dollars of funding and several inde-
pendent investigations in a number of countries [8], the
increased morbidity of GWV remains an unexplained
phenomenon. Media interest and anecdotal reports have
fuelled speculation concerning the existence of a Gulf War
syndrome (GWS), linking reports of ill health to certain
hazardous exposures experienced during the conflict.
Most notably these include anti-chemical warfare nerve
agent prophylaxis (NAPS), depleted uranium, multiple
vaccinations, smoke from oil fires and pesticide use. It is
hypothesised that exposure to these hazards has led to the
development of a unique syndrome among some GWV,
including symptoms of post-traumatic stress disorder [4],
fibromyalgia [9], chronic fatigue [1,10] and multiple
chemical sensitivity [10,11]. However, attempts to specify
and measure the syndrome have led to contradictory find-
ings and interpretations [12]. Current opinion does not
support the existence of a unique syndrome affecting
GWV, but findings support an excess of non-specific self-
reported ill health in this group [13,14].
This is the largest UK study of post-Gulf War morbidity to
date, and the first to approach all veterans of the Gulf war
(rather than a sample), including both serving and dis-
charged personnel. The questionnaire focused on repro-
duction and child health, but a page was included which
asked for information on the study participants' changes
in health status since 1990. Since the focus of the study
was on reproduction and child health, we reasoned that
selection bias relating to the ill health of the veterans
themselves might be reduced. Previous studies have
included tick-boxes or grading scales with a list of possible
symptoms for respondents to mark and GWV have tended
to report increased frequencies of almost all symptoms
included in questionnaires [1,3,4]. In contrast, we asked
participants to respond to an open-ended question about
'any new medical problems or changes in general health
since 1990'. By allowing veterans to report on a full and
non-specific range of symptoms using free text it was
hoped that they would report only those symptoms which
they felt were most important to them.
The main objective of this analysis was to quantify and
describe symptoms and diseases reported by UK GWV and
a comparison group since 1990. We aimed to determine
whether GWV still report more ill health, and/or a differ-
ent profile of symptoms and diseases than NGWV when,
i) their children's rather than their own health was the
focus of the study; and ii) details of their own ill health
were requested in a non-specific way using free-text. In
addition, we aimed to estimate the number of GWV who
believed that they had Gulf war syndrome (GWS), and to
compare their reported disease/symptom profiles with
GWV who did not believe they had the syndrome.
Methods
Full details of the study are reported elsewhere [15]. In
brief, the Gulf War cohort (GWV) consisted of all UK
armed forces personnel deployed to the Gulf area at any
time between August 1990 and June 1991 (51,581 men
and 1,230 women). Special forces were excluded for secu-
rity reasons. The comparison cohort (NGWV) comprised
demographically similar personnel who were in service
on 1st January 1991 and were appropriately fit, but were
not deployed to the Gulf (51,688 men and 1,236
women). The group was stratum-matched on sex, age
(five-year groups), service (Army, Navy, Air Force), rank
(officer, other ranks), serving status at the time of the Gulf
War (regular, reservist) and on fitness to be deployed
(Army and Air Force only). 42,818 men and 1,269 women
responded to the survey, representing response rates of
48% and 66% respectively after adjusting for undelivered
mail. For reasons of statistical power, the analyses
reported in this paper were restricted to the 42,818 male
responders.
Basic demographic details and last known address for all
surviving cohort members were obtained from the Minis-
try of Defence (MoD). Information was collected using a
validated postal questionnaire sent to both serving and
discharged military personnel between August 1998 and
March 2001. In addition to questions on reproduction
and pregnancy outcome, information was collected on
the study participant's current health, and on changes in
health status since 1990. Questions on service history,
smoking status, current alcohol consumption, and details
of vaccinations and exposure to specific chemical and
environmental factors during the Gulf war (1990–91 for
NGWV) were included. GWV were also asked if they con-
sidered that they had 'Gulf War syndrome' (Yes /No/Not
Sure). Missing information was checked by letter or tele-
phone, and an Intensive Tracing Study (ITS) of non-
responders was conducted.
The primary outcome measure was the reporting of one or
more new medical problems or changes in general health
since 1990. Reported symptoms/diseases were coded into
one of 36 different categories (based loosely on ICD-10
classification), and the data were examined by these ill
health categories. Subjects were counted only once in theBMC Public Health 2004, 4:27 http://www.biomedcentral.com/1471-2458/4/27
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analysis if they had more than one symptom in the same
category.
Statistical analysis
All analyses were performed using Stata 7.0 statistical soft-
ware [16]. All p-values quoted are two-sided and values
less than 0.05 were taken to indicate statistical signifi-
cance. t-tests were conducted on log transformed data to
compare the average number of ill health categories
reported per subject in different groups. The association
between deployment and ill health was explored using
logistic regression analysis, calculating odds ratios and
95%CIs (with NGWV as baseline) for each ill health cate-
gory. We adjusted for age at survey, service, rank, serving
status at time of survey, smoking status and current alco-
hol consumption in all models.
Results
Response
Data supplied by all male respondents are analysed here
(24,379 GWV; 18,439 NGWV). Characteristics of these
men and of those reporting one or more medical prob-
lems arising since 1990 are presented in Table 1. GWV
responders were slightly younger than NGWV responders,
and were more likely to have served in the Army, to not be
an officer, to have left the Armed Services, to have ever
smoked, and to have consumed larger amounts of alco-
hol. However, the differences in the distributions were not
large. Among those reporting one or more medical symp-
tom/disease, GWV were again younger, more likely to
serve in the Army, to not be an Officer, and to have ever
smoked.
Symptoms/diseases
61% of GWV reported at least one new medical symptom
since 1990 compared with 37% of NGWV (adjusted OR
2.7, 95% CI 2.5–2.8). The data are presented by ill health
category in Table 2 in order of frequency of reporting by
GWV (highest to lowest). The most common symptoms/
diseases reported by GWV were skeletal and other muscu-
lar symptoms (15.1%), 'other' symptoms (13.1%), gen-
eral fatigue (10.8%), memory loss/lack of concentration
(7.9%) and skin allergies (7.6%). Accidental injury
(2.6%) was among one of the most common ill health
categories reported by NGWV. Overall, GWV reported sig-
nificantly more symptoms/diseases than NGWV. Among
all those reporting one or more new symptom/disease
since 1990, GWV reported a median of two different ill
health categories per subject (range 1–23), while NGWV
reported a median of one (range 1–17) (p < 0.001).
For over 85% of categories of ill health, symptom/disease
prevalence was higher among GWV (Figure 1; Table 2).
Strongest associations with Gulf war service included
mood swings (OR 20.9, 95%CI 16.2–27.0), memory loss/
lack of concentration (OR 19.6, 95% CI 15.5–24.8), night
sweats (OR 9.9, 95% CI 6.5–15.2), general fatigue (OR
9.6, 95% CI 8.3–11.1) and sexual dysfunction (OR 4.6,
95%CI 3.2–6.6). Adjustment for potential confounding
factors had little impact on these associations, none
changing the ORs by more than about 3–4% on average.
Gulf War syndrome (GWS) among GWV
23,103 GWV answered the question "Do you consider
that you have "Gulf War Syndrome"?". 5.6% believed that
they had the syndrome (GWS) and 40.9% stated that they
were 'unsure' (Table 1). Among all GWV reporting one or
more new symptom/disease since 1990, veterans who
believed that they had GWS reported the highest number
of different symptoms/diseases (median = 3; range 1–23),
with those who were unsure (unsure-GWS) reporting
more symptoms/diseases (median = 2; range 1–15) than
those who stated that they did not (non-GWS) (median =
1; range 1–10 categories per subject); (χ2
trend: p < 0.001).
For all but one ill health category (accidental injury),
those who believed that they had GWS reported the high-
est symptom/disease prevalence, with unsure-GWS
reporting intermediate frequencies for all categories
(Table 3; Figure 2).
Discussion
This is the largest study of male UK veterans of the first
Gulf war and the only one to approach all those deployed.
Unlike other Gulf war studies, information on ill health
arising since the war was collected using free text. Our
study confirmed that GWV were significantly more likely
to report at least one new medical problem since 1990
than a non-deployed comparison group. It also confirmed
that veterans were more likely to report higher numbers of
symptoms/diseases. These typically included skeletal and
other muscular symptoms, general fatigue, memory loss/
lack of concentration, skin allergies, mood swings/aggres-
sion and headaches. This pattern of symptom reporting is
similar to that found in other studies of UK GWV [1-3],
which looked at the same populations using different
methods. For example, Unwin et al [1] found that GWV
reported  all  symptoms (in pre-defined categories) at
higher frequencies than NGWV in their study of a sample
of UK veterans with two matched comparison groups,
while we found that GWV reported higher prevalence in
85% of ill health categories.
In terms of the nature of self-reported ill health, we found
similar results to the range of symptoms that have been
reported elsewhere. Gray et al's [17] study of GWV found
that over 50 percent of diagnoses could be classified into
four large categories: diseases of the musculoskeletal sys-
tem and connective tissue (19.0%), mental disorders
(14.7%), diseases of the respiratory system (10.5%) and
diseases of the skin and subcutaneous tissue (9.4%). InBMC Public Health 2004, 4:27 http://www.biomedcentral.com/1471-2458/4/27
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our study the same four categories accounted for 50.3
percent of all reported symptoms/diseases and this figure
rises to over 70 percent when the categories of fatigue and
nervous system disorders are included. An additional
point concerns the higher levels of accidental injury
reported by NGWV veterans; accidents were only half as
likely to occur among GWV compared to NGWV (1.3%
versus 2.6%). This was surprising as mortality from acci-
dents has repeatedly been found to be raised among GWV
[18]. This difference is probably due to the inclusion of
both major and minor injuries (including those resulting
in bone fractures) in our study, and because GWV may be
more inclined to report things they think are associated
with their Gulf War service.
Our findings on Gulf War syndrome (GWS) approximate
those from other studies [12-14,19,20]. A significant pro-
portion of GWV believed that they had GWS (5.6%) and
this belief was associated with increased symptom report-
ing. This figure was lower than that reported by other
studies (Chalder et al [12] found that 17.3% of GWV
believed that they had GWS), but we are the first group to
report on a large proportion of GWV who were 'unsure' of
their GWS-status (40.9%). 'Unsure' veterans generally
reported intermediate frequencies of ill health between
those veterans who believed that they had GWS and those
that did not. In a sample of UK veterans, Chalder et al [12]
found that those who believed they had GWS were more
fatigued, more distressed, and more likely to have a post-
traumatic stress reaction than veterans who did not
believe they suffered from GWS. Our data showed that
GWS veterans reported higher frequencies of all categories
of ill health (except accidental injury), including skeletal
and other muscular symptoms, general fatigue, mood
Table 1: Characteristics of all male responders, and of those reporting one or more new medical symptom since 1990
Variable ALL MALE RESPONDERS1 MALE RESPONDERS REPORTING ≥ 1 NEW
MEDICAL SYMPTOM/DISEASE SINCE 19901
GWV NGWV GWV NGWV
n (%) n (%) n (%) n (%)
Total 24,379 (100) 18,439 (100) 14,411 (100) 6,670 (100)
Age at time of survey (years)
20–29 5,506 (23) 3,442 (19) 3,361 (23) 1,295 (19)
30–34 7,871 (32) 5,754 (31) 4,523 (31) 1,951 (29)
35–39 5,492 (23) 4,399 (24) 3,222 (22) 1,462 (22)
40–44 3,019 (12) 2,500 (14) 1,797 (13) 943 (14)
≥45 2,491 (10) 2,343 (13) 1,508 (11) 1,019 (15)
Mean (SD) 35(6.8) 36(7.3) 35(6.8) 36(7.9)
Service at time of Gulf War2
Army 17,106 (70) 12,559 (68) 10,619 (74) 4,750 (71)
RN 2,417 (10) 2,110 (11) 1,227 (9) 658 (10)
RAF 4,856 (20) 3,770 (21) 2,565 (18) 1,262 (19)
Rank at time of Gulf War2
Officer 3,202 (13) 3,062 (17) 1,616 (11) 1,068 (16)
Other ranks 21,177 (87) 15,377 (83) 12,795 (89) 5,602 (84)
Serving status at time of survey
Still serving 13,259 (54) 10,553 (57) 7,293 (51) 3,366 (51)
No longer serving 11,120 (46) 7,886 (43) 7,118 (49) 3,304 (50)
Smoking
Ever 13,514 (57) 9,716 (54) 8,468 (59) 3,784 (57)
Never 10,390 (44) 8,379 (46) 5,865 (41) 2,870 (43)
Alcohol intake at time of survey (units per week)
None 1,514 (7) 1,190 (7) 1,056 (8) 531 (8)
1–3 3,269 (14) 2,377 (13) 2,093 (15) 1,002 (15)
4–10 8,838 (38) 6,848 (39) 5,169 (37) 2,398 (37)
11–20 6,173 (26) 4,767 (27) 3,548 (25) 1,638 (25)
≥21 3,632 (16) 2,538 (14) 2,180 (16) 958 (15)
"Gulf war syndrome"
Yes 1,324 (6) 1,282 (9)
No 12,577 (53) - 4,925 (35) -
Not sure 9,692 (41) - 8,041 (56) -
1Numbers for each variable might not add up to total due to missing values. 2At 1st January 1991, or at time of first deployment if known (GWV 
responders).BMC Public Health 2004, 4:27 http://www.biomedcentral.com/1471-2458/4/27
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Table 2: Summary of self-reported symptoms/diseases by deployment (ordered by frequency of reported ill health categories among 
GWV)
Self-reported symptom Frequency (%) GWV vs. NGWV
GWV1(n = 23,358)2 NGWV1(n = 17,730)2 Adjusted odds ratio 3 (95% CI)
All reporting ≥ 1 new symptom/disease since 1990 14,1742 (60.7) 6,5052 (36.7) 2.7 (2.5–2.8)***
Mental and behavioural disorders 4,691 (20.1) 634 (3.6) 6.7 (6.1–7.3)***
Memory loss / lack of concentration 1,883 (7.9) 76 (0.4) 19.6 (15.5–24.8)***
Mood swings / aggression / irritability 1,712 (7.3) 62 (0.4) 20.9 (16.2–27.0)***
Anxiety / stress / sleep disturbance 1,212 (5.2) 272 (1.5) 3.4 (3.0–3.9)***
Depression 1,005 (4.3) 203 (1.1) 3.6 (3.1–4.2)***
PTSD and associated symptoms (mentioned specifically) 231 (1.0) 68 (0.4) 2.4 (1.8–3.1)***
Sexual dysfunction / lack of sex drive 192 (0.8) 35 (0.2) 4.6 (3.2–6.6)***
Other psychiatric / psychological disorders NOS4 380 (1.6) 65 (0.4) 3.9 (3.0–5.1)***
Musculo-skeletal & connective tissue disorders 3,807 (16.3) 2,387 (13.5) 1.2 (1.2–1.3)***
Skeletal & other muscular symptoms 3,523 (15.1) 2,346 (13.2) 1.1 (1.1–1.2)***
Muscular pain / weakness (mentioned specifically) 460 (2.0) 77 (0.4) 4.5 (3.5–5.7)***
Other symptoms NOS4 3,058 (13.1) 1,146 (6.5) 2.2 (2.0–2.3)***
Fatigue 2,632 (11.3) 236 (1.3) 9.1 (8.0–10.5)***
General fatigue 2,532 (10.8) 215 (1.2) 9.6 (8.3–11.1)***
Chronic fatigue syndrome / ME (mentioned specifically) 100 (0.4) 21 (0.1) 3.5 (2.1–5.5)***
Nervous system disorders 2,104 (9.0) 435 (2.5) 3.8 (3.4–4.2)***
Headaches 1,554 (6.7) 280 (1.6) 4.2 (3.7–4.8)***
Numbness / tingling / dizziness 460 (2.0) 93 (0.5) 3.6 (2.9–4.6)***
Epilepsy 53 (0.2) 21 (0.1) 1.6 (1.0–2.7)
Other neurological and neuromuscular problems NOS4 217 (0.9) 68 (0.4) 2.4 (1.8–3.1)***
Infection 1,898 (8.1) 606 (3.4) 2.5 (2.3–2.7)***
Chronic / frequent infection 1,351 (5.8) 278 (1.6) 3.8 (3.3–4.3)***
Single episodes of acute infection 635 (2.7) 351 (2.0) 1.4 (1.2–1.6)***
Skin allergies 1,782 (7.6) 414 (2.3) 3.3 (3.0–3.7)***
Respiratory disorders 1,468 (6.3) 569 (3.2) 2.0 (1.8–2.2)***
Asthma 608 (2.6) 374 (2.1) 1.2 (1.1–1.4)**
Respiratory problems NOS4 898 (3.8) 204 (1.2) 3.3 (2.9–3.9)***
Digestive, stomach & intestinal disorders 1,377 (5.9) 538 (3.0) 2.0 (1.8–2.2)***
Deterioration in general health 852 (3.7) 510 (2.9) 1.3 (1.1–1.4)***
General deterioration of eyesight / hearing 582 (2.5) 465 (2.6) 1.0 (0.8–1.1)
General decline in fitness / health 280 (1.2) 48 (0.3) 4.4 (3.2–6.0)***
Cardiovascular disorders 675 (2.9) 442 (2.5) 1.3 (1.1–1.4)***
Endocrine, nutritional and metabolic disorders 624 (2.7) 210 (1.2) 2.2 (1.9–2.6)***
Hormonal imbalance / problems 70 (0.3) 38 (0.2) 1.5 (1.0–2.2)
Diabetes 57 (0.2) 64 (0.4) 0.7 (0.5–1.0)
Weight gain / loss 504 (2.2) 109 (0.6) 3.4 (2.7–4.1)***
Genito-urinary system disorders 464 (2.0) 198 (1.1) 1.8 (1.5–2.1)***
Genital system & bladder problems5 276 (1.2) 99 (0.6) 2.2 (1.7–2.7)***
Kidney disease / symptoms 209 (0.9) 103 (0.6) 1.5 (1.2–1.9)**
Chest pains / tightness (not elsewhere classified) 399 (1.7) 134 (0.8) 2.2 (1.8–2.6)***
Allergies other than skin 369 (1.6) 161 (0.9) 1.8 (1.5–2.1)***
Night sweats / excessive sweating / "fevers" 315 (1.4) 23 (0.1) 9.9 (6.5–15.2)***
Accidental injury 294 (1.3) 460 (2.6) 0.5 (0.4–0.5)***
Auto-immune disease 241 (1.0) 196 (1.1) 1.0 (0.8–1.2)
Cancer6 127 (0.5) 88 (0.5) 1.1 (0.9–1.5)
1Subject can appear in the table as many times as they reported different symptoms. More than one symptom within a group in the same subject 
counted once only. Number of symptoms in sub-groups may not add up to group total if more than one symptom was recorded within the group 
for the same subject. 2Denominators and number of veterans reporting ≥ 1 new symptom/disease since 1990 are different to the numbers reported 
in Table 1 as some respondents did not give specific details of their symptoms/diseases and could not therefore be included in this table. 3Adjusted 
for age at survey, service and rank at time of Gulf war, serving status at time of survey, alcohol consumption and smoking. 4Not Otherwise Specified 
(NOS) 5Category includes those reporting 'burning semen' GWV 13 (0.1%); NGW 1 (0.0%) 6Includes all reported malignant neoplasms, plus all 
reported brain tumours, benign or malignant. * 0.01 < p < 0.05 ** 0.001 < p < 0.01 *** p < 0.001BMC Public Health 2004, 4:27 http://www.biomedcentral.com/1471-2458/4/27
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Table 3: Summary of self-reported symptoms/diseases among GWV by GWS status (ordered by frequency of reported ill health 
categories among GWS)
Self-reported symptom Frequency (%) Adjusted2 odds ratio (95% CI)
GWS1
(n = 1,296)
unsure-GWS1
(n = 9,443)
non-GWS1
(n= 12,364)
GWS vs non-GWS unsure GWS vs. non-GWS
All reporting ≥ 1 new symptom /
disease since 1990
1,260 (97.2) 7,929 (84.0) 4,830 (39.1) 48.2 (34.5–67.4)*** 8.0 (7.5–8.6)***
Mental and behavioural disorders 775 (59.8) 3,076 (32.6) 793 (6.4) 18.3 (15.9–21.0)*** 6.6 (6.0–7.1)***
Memory loss / lack of concentration 295 (22.8) 1,249 (13.2) 274 (2.2) 12.1 (10.0–14.7)*** 6.6 (5.7–7.5)***
Mood swings / aggression / 
irritability
327 (25.2) 1,147 (12.2) 214 (1.7) 16.1 (13.2–19.7)*** 6.9 (5.9–8.0)***
Anxiety / stress / sleep disturbance 220 (17.0) 769 (8.1) 213 (1.7) 10.8 (8.7–13.5)*** 4.7 (4.1–5.6)***
Depression 245 (18.9) 613 (6.5) 137 (1.1) 16.1 (12.7–20.4)*** 5.5 (4.5–6.6)***
PTSD and associated symptoms 
(mentioned specifically)
91 (7.0) 116 (1.2) 21 (0.2) 34.9 (20.8–58.7)*** 6.4 (4.0–10.5)***
Sexual dysfunction / lack of sex drive 42 (3.2) 123 (1.3) 27 (0.2) 13.1 (7.7–22.3)*** 6.4 (4.2–9.9)***
Other psychiatric / psychological 
disorders NOS3
93 (7.2) 237 (2.5) 47 (0.4) 14.7 (10.0–21.7)*** 5.7 (4.1–7.9)***
Musculo-skeletal & connective 
tissue disorders
500 (38.6) 2,118 (22.4) 1,156 (9.4) 5.3 (4.6–6.1)*** 2.6 (2.4–2.9)***
Skeletal & other muscular symptoms 441 (34.0) 1,944 (20.6) 1,107 (9.0) 4.5 (3.9–5.2)*** 2.5 (2.3–2.7)***
Muscular pain / weakness 
(mentioned specifically)
122 (9.4) 265 (2.8) 68 (0.6) 16.2 (11.7–22.5)*** 5.1 (3.9–6.7)***
Fatigue 462 (35.7) 1,742 (18.5) 397 (3.2) 15.4 (13.1–18.2)*** 6.9 (6.1–7.7)***
General fatigue 405 (31.3) 1,707 (18.1) 389 (3.2) 13.1 (11.1–15.5)*** 6.8 (6.1–7.7)***
Chronic fatigue syndrome / ME 
(mentioned specifically)
57 (4.4) 35 (0.4) 8 (0.1) 65.3 (29.4–145.1)*** 6.1 (2.8–13.5)***
Other symptoms NOS3 407 (31.4) 1,720 (18.2) 908 (7.3) 5.4 (4.7–6.3)*** 2.8 (2.6–3.1)***
Nervous system disorders 373 (28.8) 1,284 (13.6) 415 (3.4) 10.0 (8.4–11.8)*** 4.1 (3.6–4.6)***
Headaches 266 (20.5) 958 (10.2) 308 (2.5) 8.7 (7.2–10.6)*** 3.9 (3.4–4.5)***
Numbness / tingling / dizziness 101 (7.8) 270 (2.9) 82 (0.7) 9.4 (6.8–12.9)*** 4.0 (3.1–5.2)***
Epilepsy 12 (0.9) 30 (0.3) 9 (0.1) 13.0 (5.0–34.1)*** 3.5 (1.6–7.5)**
Other neurological and 
neuromuscular problems NOS3
61 (4.7) 114 (1.2) 36 (0.3) 14.3 (9.1–22.5)*** 4.2 (2.8–6.2)***
Skin allergies 242 (18.7) 994 (10.5) 531 (4.3) 4.9 (4.1–5.9)*** 2.5 (2.3–2.8)***
Digestive, stomach & intestinal 
disorders
194 (15.0) 813 (8.6) 355 (2.9) 5.5 (4.5–6.7)*** 3.2 (2.8–3.7)***
Respiratory disorders 194 (15.0) 860 (9.1) 400 (3.2) 5.1 (4.2–6.2)*** 3.0 (2.6–3.4)***
Asthma 71 (5.5) 342 (3.6) 188 (1.5) 3.8 (2.8–5.1)*** 2.5 (2.1–3.0)***
Respiratory problems NOS3 128 (9.9) 540 (5.7) 222 (1.8) 5.6 (4.4–7.2)*** 3.2 (2.7–3.8)***
Infection 164 (12.7) 1,102 (11.7) 609 (4.9) 2.9 (2.4–3.5)*** 2.6 (2.4–2.9)***
Chronic / frequent infection 122 (9.4) 842 (8.9) 372 (3.0) 3.5 (2.8–4.4)*** 3.3 (2.9–3.7)***
Single episodes of acute infection 55 (4.2) 319 (3.4) 253 (2.1) 2.2 (1.6–3.0)*** 1.8 (1.5–2.1)***
Endocrine, nutritional and 
metabolic disorders
116 (9.0) 366 (3.9) 134 (1.1) 7.4 (5.6–9.8)*** 3.4 (2.8–4.2)***
Hormonal imbalance / problems 14 (1.1) 36 (0.4) 20 (0.2) 7.0 (3.3–14.8)*** 2.4 (1.4–4.2)***
Diabetes 8 (0.6) 29 (0.3) 20 (0.2) 3.3 (1.4–7.9)*** 2.0 (1.1–3.6)*
Weight gain / loss 95 (7.3) 306 (3.2) 95 (0.8) 8.0 (5.8–10.9)*** 3.9 (3.1–4.9)***
Deterioration in general health 92 (7.1) 494 (5.2) 256 (2.1) 3.2 (2.5–4.2)*** 2.5 (2.1–2.9)***
General deterioration of eyesight / 
hearing
53 (4.1) 310 (3.3) 212 (1.7) 2.2 (1.6–3.0)*** 1.9 (1.5–2.2)***
General decline in fitness / health 41 (3.2) 191 (2.0) 45 (0.4) 8.3 (5.1–13.5)*** 5.7 (4.1–8.0)***BMC Public Health 2004, 4:27 http://www.biomedcentral.com/1471-2458/4/27
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swings, memory loss/lack of concentration and head-
aches. In common with results from other studies of GWV
[13,14,19,21], those who stated that they had Gulf War
syndrome reported the same types of symptoms as all
GWV, but reported them at higher frequencies, providing
evidence against a unique syndrome.
Study limitations
In the absence of an official register or a mandatory health
evaluation programme, obtaining accurate information
from post-combat veterans is a difficult process and one
which inevitably relies on self-reporting. This method of
data collection introduces possible selection bias into a
study. After adjusting for undelivered mail, response rates
among men were 53% for GWV and 42% for NGWV [15].
Given the relatively low response rate, an intensive tracing
study of non-responders was conducted to investigate
possible selection bias. Data from the study indicated that
the majority of reasons given for previous non-participa-
tion were entirely unrelated to reproduction or Gulf War
service. Ninety percent of the reasons given by both GWV
and NGWV for earlier non-response related to such things
as not remembering receiving a questionnaire, thinking
they had sent it back, or general 'mistrust' of the MoD
[15]. It might therefore be concluded that response bias
relating to adverse health outcomes was not large in this
study.
In terms of suitable controls, an advantage of this study
was the comparison of GWV with another military cohort.
Comparisons with civilian populations may have been
misleading as military recruitment involves medical and
fitness screening. Furthermore, 'healthy warrior' bias
(where veterans deployed to the Gulf might be healthier
than those who were not deployed) [22-24] is unlikely to
account for the findings in our study because the
comparison group were broadly matched to the GWV on
fitness to be deployed.
A potential problem with any retrospective study design is
recall bias. The questionnaire asked veterans to consider
any new medical problems or changes in general health
they had experienced since the end of the Gulf War, and
this involved them recalling events that might have hap-
pened up to seven or eight years in the past. During this
time there has been much media speculation over Gulf
War illness and this may have introduced recall bias and
led to under- or over-reporting of certain symptoms. Gray
et al have shown that participation in Gulf War health reg-
istries is greatly influenced by media attention and is
likely to be influenced by compensation issues. This was
illustrated by increased enrollment during periods of high
media interest in Gulf War issues [17]. A further limitation
of this study concerns the lack of clinical validation of self-
reported ill health. However, conducting clinical exami-
Cardiovascular disorders 90 (6.9) 344 (3.6) 237 (1.9) 3.8 (2.9–5.0)*** 2.1 (1.8–2.5)***
Genito-urinary system disorders 77 (5.9) 238 (2.5) 143 (1.2) 5.3 (3.9–7.2)*** 2.3 (1.8–2.8)***
Genital system & bladder problems4 46 (3.6) 150 (1.6) 79 (0.6) 6.1 (4.0–9.2)*** 2.7 (2.0–3.6)***
Kidney disease / symptoms 35 (2.7) 101 (1.1) 68 (0.6) 4.4 (2.8–6.9)*** 1.9 (1.4–2.6)***
Night sweats / excessive sweating / 
"fevers"
77 (5.9) 185 (2.0) 49 (0.4) 13.7 (9.2–20.2)*** 4.7 (3.4–6.5)***
Chest pains / tightness (not 
elsewhere classified)
56 (4.3) 253 (2.7) 87 (0.7) 5.5 (3.8–7.9)*** 3.3 (2.6–4.3)***
Auto-immune disease 37 (2.9) 136 (1.4) 64 (0.5) 5.2 (3.3–8.1)*** 2.8 (2.1–3.8)***
Allergies other than skin 31 (2.4) 197 (2.1) 136 (1.1) 2.7 (1.8–4.1)*** 2.2 (1.7–2.8)***
Cancer5 19 (1.5) 61 (0.7) 42 (0.3) 5.1 (2.8–9.2)*** 2.3 (1.5–3.4)***
Accidental injury 14 (1.1) 128 (1.4) 146 (1.2) 0.9 (0.5–1.5) 1.1 (0.8–1.4)
1Subject can appear in the table as many times as they reported different symptoms. More than one symptom within a group in the same subject 
counted once only. Number of symptoms in sub-groups may not add up to group total if more than one symptom was recorded within the group 
for the same subject. 2Adjusted for age at survey, service and rank at time of Gulf war, serving status at time of survey, alcohol consumption and 
smoking. 3Not Otherwise Specified (NOS) 4Category includes those reporting 'burning semen' GWS 6 (0.5%); unsure-GWS 5 (0.1%); non-GWS 2 
(0.0%) 5Includes all reported malignant neoplasms, plus all reported brain tumours, benign or malignant. * 0.01 < p < 0.05 ** 0.001 < p < 0.01 *** p 
< 0.001
Table 3: Summary of self-reported symptoms/diseases among GWV by GWS status (ordered by frequency of reported ill health 
categories among GWS) (Continued)BMC Public Health 2004, 4:27 http://www.biomedcentral.com/1471-2458/4/27
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nations and psychiatric assessments of every veteran
would have been time consuming and prohibitively
expensive. Furthermore, studies looking at 'hard' clinical
diagnoses or more objective outcomes, such as cancer [25]
or hospitalisation rates [26], have shown no important
differences between GWV and comparison groups.
Researchers have concentrated instead on differences in
'softer' endpoints [1-3], which are similar to those
reported here.
Conclusions
This study is consistent with other research showing a sig-
nificant excess of morbidity among GWV. It also confirms
the lack of specificity in post-Gulf war illness. These find-
ings were replicated despite the fact that reproduction and
child health were the focus of the study (rather than the
veterans' general health), and questions relating to the
veterans' own health were open-ended. Research groups
have linked post-Gulf War ill health to a number of self-
reported exposures but these analyses are limited by a lack
of independent individual-level exposure data [1,27,28].
It has been suggested that changes in perception resulting
from the disruption of war rather than specific exposures
might be responsible [3], and there have been calls to
move away from this narrow focus [29]. In the Gulf, dis-
ruption included change of climate, living conditions,
diet, sleeping patterns, physical activity and separation
from family, as well as the threat of chemical and biolog-
ical weapons [27]. Despite such conjecture, explaining the
increased ill health of GWV remains a controversial sub-
ject and there is no real consensus of opinion. In order for
more rigorous aetiological studies of post-conflict illness
to be undertaken in the future, there is a need to improve
routine health surveillance and record-keeping both pre-
and post- deployment [30]. This surveillance should also
translate into more effective prevention and treatment
programs in order to reduce the burden of post-war ill-
ness. Further research on the mechanisms underlying the
Prevalence of self-reported ill health categories by deployment to the Gulf war (ordered by frequency of reported ill health  categories among GWV) Figure 1
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reporting of ill health is required and this will entail a
more qualitative approach to the problem of Gulf War ill-
ness. Continued quantitative documentation of the long-
term health outcomes of Gulf War veterans remains
essential.
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